Prevail Innovative Wealth Advisors’s Abbott ABT Stock Holding History

Prevail Innovative Wealth Advisors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.83M	Buy	+31,178	New	+$2.85M	0.42%	91

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prevail Innovative Wealth Advisors's ABT Position: Q2 2026 in Review

Prevail Innovative Wealth Advisors opened a new position in Abbott (ABT) in Q2 2026: 31,178 shares worth $2.83M. The stake represents 0.42% of the portfolio and ranks #91 among its holdings.

2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Prevail Innovative Wealth Advisors held 31,178 shares of Abbott worth $2.83M as of Q2 2026.
Abbott was a new Prevail Innovative Wealth Advisors position in Q2 2026.
Abbott made up 0.42% of Prevail Innovative Wealth Advisors's portfolio in Q2 2026, its #91 holding.
2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Prevail Innovative Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.